balixafortide
balixafortide
| SMILES | CC1NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C2CCCN2C(=O)C2CCCN2C(=O)C(CCCCN)NC(=O)C(CCC(N)=O)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C2CSSCC(NC1=O)C(=O)NC(CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)N2 |
| InChIKey | MKXOUIKTXREBLX-NDKBASPVSA-N |
Chemical Properties
| Hydrogen bond acceptors | 27 |
| Hydrogen bond donors | 24 |
| Rotatable bonds | 23 |
| Molecular weight (Da) | 1864.1 |
Database connections
No bioactivity data available.
balixafortide
Drug properties
| Molecular type | Protein |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
1
Phase III
1
Phase IV
0
Database connections
Sankey plot
, 'sankey.svg');){kind=link}
, 'sankey.png');){kind=link}
,'sankey.jpg');){kind=link}
Drug Information
| Target | Disease | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |